Clinical Trial Update: Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM) [Phase 4]

View source ↗

Summary

A Phase 4 trial update on the effect of dapagliflozin for functional mitral regurgitation and myocardial fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Mitral Regurgitation

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Functional Mitral Regurgitation | Phase 4 | Status: UNKNOWN